Wave Life Sciences Ltd.’s filing revealed that its Chief Financial Officer Moran Kyle unloaded Company’s shares for reported $96421.0 on Apr 03 ’24. In the deal valued at $6.17 per share,15,630 shares were sold. As a result of this transaction, Moran Kyle now holds 33,921 shares worth roughly $0.2 million.
Then, RA CAPITAL MANAGEMENT, L.P. bought 1,000,000 shares, generating $5,000,000 in total proceeds. Upon buying the shares at $5.00, the Director now owns 19,202,009 shares.
Before that, GSK plc bought 3,300,000 shares. Wave Life Sciences Ltd. shares valued at $16,500,000 were divested by the 10% Owner at a price of $5.00 per share. As a result of the transaction, GSK plc now holds 13,983,761 shares, worth roughly $81.39 million.
Leerink Partners upgraded its Wave Life Sciences Ltd. [WVE] rating to an Outperform from a a Market perform in a research note published on December 19, 2023; the price target was increased to $12 from $5. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. Jefferies also remained covering WVE and has decreased its forecast on May 24, 2023 with a “Hold” recommendation from previously “Buy” rating.
Price Performance Review of WVE
On Tuesday, Wave Life Sciences Ltd. [NASDAQ:WVE] saw its stock jump 0.34% to $5.82. Over the last five days, the stock has lost -6.88%. Wave Life Sciences Ltd. shares have risen nearly 15.25% since the year began. Nevertheless, the stocks have risen 31.67% over the past one year. While a 52-week high of $7.67 was reached on 03/07/24, a 52-week low of $3.15 was recorded on 02/14/24. SMA at 50 days reached $5.19, while 200 days put it at $4.97. A total of 0.34 million shares were traded, compared to the trading of 0.37 million shares in the previous session.
Levels Of Support And Resistance For WVE Stock
The 24-hour chart illustrates a support level at 5.66, which if violated will result in even more drops to 5.50. On the upside, there is a resistance level at 5.97. A further resistance level may holdings at 6.12. The Relative Strength Index (RSI) on the 14-day chart is 50.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.42%. Stochastics %K at 31.30% indicates the stock is a holding.
How much short interest is there in Wave Life Sciences Ltd.?
A steep rise in short interest was recorded in Wave Life Sciences Ltd. stocks on Mar 15, 2024, growing by 0.49 million shares to a total of 3.0 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 2.51 million shares. There was a rise of 16.33%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.43% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.16.
The most recent change occurred on October 23, 2020 when RBC Capital Mkts began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $13 price target.
